Try our Advanced Search for more refined results
IN RE: BLOOD REAGENTS ANTITRUST LITIGATION
Case Number:
2:09-md-02081
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
-
July 13, 2018
Ortho's $19.5M Deal Ending Antitrust MDL Gets Initial OK
A Pennsylvania federal judge on Thursday greenlighted Ortho-Clinical Diagnostics Inc.'s $19.5 million deal to resolve allegations in multidistrict litigation that the former Johnson & Johnson unit conspired with another company to fix prices on the reagents used in blood tests.
-
October 19, 2015
Purchasers Win Cert. Again In Blood Test Antitrust MDL
A Pennsylvania federal judge on Monday recertified a class of buyers of reagents used in blood tests in multidistrict litigation alleging that a former Johnson & Johnson unit conspired with another company to fix prices on the reagents.
-
August 23, 2012
Purchaser Class Certified In J&J Blood Test Antitrust MDL
A Pennsylvania federal judge on Wednesday said buyers of reagents used in blood tests had satisfied the requirements to certify a class in an action alleging that a Johnson & Johnson unit conspired with another company to fix prices on the reagents.
-
March 05, 2012
Immucor To Pay $22M To Stanch Blood Test Antitrust Action
Immucor Inc. has agreed to pay $22 million to resolve its part in a class action alleging it conspired with a Johnson & Johnson unit to fix prices of blood-testing reagents, according to a settlement agreement granted preliminary approval Monday.